Here are 18 key notes on orthopedic and spine device companies over the past week.
Fifty young patients have now undergone scoliosis treatment with the ApiFix system.
Arthrex paid $95 million to Smith & Nephew in connection with a patent infringement case.
Arthrex also paid KFx Medical $35 million related to another patent infringement suit.
Daniel Federowicz, MD, is the first orthopedic surgeon in the New York state region using Biomet's Vanguard XP Preserving Knee for replacement procedures.
CyMedica Orthopedics closed an extension to its Series A financing round.
DePuy Synthes signed a five-year cooperation agreement with AO Foundation that will continue a partnership dating back to 1960.
The motion preservation device market is the fastest growing segment within the U.S. spinal implant market, with DePuy Synthes leading the growth.
The first patient is enrolled in a new major multicentric clinical protocol designed to study the medical value of Implanet's Jazz Band treatment for instrumented thoracic and lumbar arthrodesis.
Intellirod Spine recently announced a number of company updates — the company secured additional equity financing and received ISO certification.
InVivo Therapeutics named James Guest, MD, PhD, to the Scientific Advisory board.
InVivo Therapeutics also appointed Ann Merrifield lead director of the company's board of directors.
Invuity began trading on June 15 on the NASDAQ Global Market.
K2M named Michael A. Turpin to the board of directors.
NuVasive elected Vickie L. Capps to the board of directors.
SpineGuard completed another round of equity totaling $3.1 million.
Analysts at Canaccord Genuity have reiterated Stryker's stock "buy" rating.
Vericel plans to submit a biologics license application to the FDA by the end of 2015 for MACI, a new biologic.
Wright Medical Group and Tornier shareholders both approved all proposals related to the combination of the two companies.